Member Info for seav1ew

Low low volume. Not too many ISAs adding new money.
Have a good long weekend all.

With my corporate hat on: when dealing with SMEs, (which are encouraged to engage in NHS procurement!), a good look at track record and current customer base will happen. Perhaps the Trust are being ultra cautious?
QVH will be starting over next year if FDBK don't continue. That would be reinventeing the wheel, and such a waste.

What exactly was the point of the Pilot phase if, when successful, (never been done before!) the solution can't be implemented throughout adding pathways as needed?
[Bangs head on wall]
Local politics and red tape or some other reason?

Any company tendering will have to have a CE marked clinical device. Who else has? If it's still no one, then how can any other company tender?
"Importantly, Bleepa is the only CE marked medical imaging communications platform on the NHSX clinical communications tools framework".

Yes, ndr, hit the nail on the head.
Going back to the company Q&A, mention of 'strong pipeline', AI related action combining MDT work.
Plus trusts not confirming to imaging standards (WhatsApp) and being very slow to adopt CE marked devices. Slow, slow adoption.

A broad market probably didn't engage with the tender as was. Could be FDBK were the only contender? Doubtless that breaches some procurement rules.
Tom must be so frustrated and some contracts outside the NHS must be a way forward.

Tom needs a Proactive interview pronto. What has happened at QVH? Are they expanding the CDC brief, if so, is Bleepa still a runner? Etc etc. NHS complexity strikes again.

No real explanation. I wonder what's happened.

Dr Tom Oakley, CEO Feedback plc said: "Although QVH had expected to conclude its tender process by 31st March 2023, we have been informed by the Trust that the existing tender process is no longer progressing. We are pleased to be supporting QVH on an interim basis to ensure the continuity of ongoing patient care whist they undertake a further procurement exercise.

Now we've passed 31 March, a reminder:

Dr Tom Oakley, CEO of Feedback, said: "QVH and the broader Sussex team have been great partners in delivering this end-to-end clinical solution. This contract recognises the initial stage of our work together and enables us to proceed to a more formal working arrangement, pending a successful procurement exercise.

GLA

Thanks Vas & Barnacle, good stuff.
And of course we know that :
Bleepa is the only communications platform being used by the NHS to be certified as UKCA marked.
Ticks all the boxes.
Could be an interesting year.

More gas required in the region, I wonder where there's some?!

I was quite surprised it didn't win. However, let's face it, Bleepa looks great, and with added care pathways an unmissable application for the NHS and beyond.

Thanks Vascular and ndr50.
Certainly that's a huge area to add into the whole care record. It's fragmented right now. Who talked about digital glue? Right!

You'd imagine QVH tender has a result by now. Radio silence. Let's hope we hear today or tomorrow, or will they leave it until Monday?

Stock Exchange email just now. Production this week, subject to final formal approvals from certain Zimbabwean authorities.

Incredibly sloppy. I would be wearing a suit earning £30k!
What did the rest of the management think about it?
Come on!

It's a very specific tech driven approach, it doesn't sound like Feedback's main USP. Looks back to front.
Patient pathways is where we are.

Yes PR, and yet on insignificant volumes we are dropping. Perhaps stock is being hunted. Definitely a pivotal moment here. GLA

533,386 Options though

Thanks CDF. Eye-opening.
Massive challenges ahead.